Delayed HIV diagnosis and initiation of antiretroviral therapy: Inequalities by educational level, COHERE in EuroCoord

AIDS

Volumn 28, Issue 15, 2014, Pages 2297-2306

  Zangerle, Robert ^a   Touloumi, Giota ^a   Warszawski, Josiane ^a   Meyer, Laurence ^a   Dabis, François ^a   Krause, Murielle Mary ^b   Ghosn, Jade ^c   Leport, Catherine ^d   Reiss, Peter ^e   Wit, Ferdinand ^e   Prins, Maria ^a   Bucher, Heiner ^a   Sabin, Caroline ^f   Gibb, Diana ^a   Fätkenheuer, Gerd ^a   Del Amo, Julia ^a   Obel, Niels ^a   Thorne, Claire ^a   Mocroft, Amanda ^a   Kirk, Ole ^a   Stephan, Christoph ^a   Pérez Hoyos, Santiago ^a   Hamouda, Osamah ^a   Bartmeyer, Barbara ^a   Noguera Julian, Antoni ^a   Antinori, Andrea ^a   D'Arminio Monforte, Antonella ^a   Brockmeyer, Norbert ^a   Ramos, Josè ^a   Conejo, Pablo Rojo ^g   Soriano, Toni ^a   Battegay, Manuel ^a   Rauch, Andri ^a   Mussini, Cristina ^a   Tookey, Pat ^a   Casabona, Jordi ^a   Mirò, Jose M ^a   Castagna, Antonella ^a   Konopnick, Deborah ^a   Goetghebuer, Tessa ^a   Torti, Carlo ^a   Teira, Ramon ^a   Garrido, Myriam ^a   Haerry, David ^a   De Wit, Stéphane ^h   Costagliola, Dominique ^a   Grarup, Jesper ⁱ   Chêne, Genevieve ^j   Cohort, Paediatric ^a   Judd, Ali ^a   Bohlius, Julia ^a   Bouteloup, Vincent ^a   Cozzi Lepri, Alessandro ^a   Dorrucci, Maria ^a   Egger, Matthias ^a   Engsig, Frederik ^a   Furrer, Hansjakob ^a   Lambotte, Olivier ^a   Lodi, Sara ^k   Matheron, Sophie ^a   Monge, Susana ^a   Nakagawa, Fumiyo ^a   Paredes, Roger ^a   Phillips, Andrew ^a   Puoti, Massimo ^a   Smit, Colette ^a   Sterne, Jonathan ^a   Thiebaut, Rodolphe ^a   Van Der Valk, Marc ^a   Wittkop, Linda ^a   Wyss, Natasha ^a   more..

^a AHIVCOS ^*

^b ANRS CO4 FHDH   (France)

^c ANRS CO6 PRIMO   (France)

^d ANRS CO8 COPILOTE   (France)

^e Espace ATHENA   (France)

^f CHIC   (France)

^g ANRS CO6 PRIMO ^*  (Spain)

^h SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

ⁱ UPMC Univ Paris 06   (Denmark)

^j Bordeaux Regional Coordinating Centre   (Denmark)

^k HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

more..

Author keywords

Antiretroviral therapy; Education; Hiv; Late diagnosis; Socioeconomic inequities

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR;

ADOLESCENT; ADULT; ANTIVIRAL THERAPY; ARTICLE; AUSTRIA; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; DELAYED DIAGNOSIS; EDUCATIONAL STATUS; FEMALE; FRANCE; GREECE; HEALTH CARE DISPARITY; HEALTH EDUCATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ITALY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SPAIN; SWITZERLAND; THERAPY DELAY; TIME TO TREATMENT; TREND STUDY;

EID: 84927758945     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000410     Document Type: Article

References (36)

1. Dray-Spira R, Lert F. Social health inequalities during the course of chronic HIV disease in the era of highly active antiretroviral therapy. AIDS 2003; 17:283-290.
2. Marmot M, Friel S, Bell R, Houweling TA, Taylor S. Closing the gap in a generation: health equity through action on the social determinants of health. Lancet 2008; 372:1661-1669.
3. Marmot M, Allen J, Bell R, Bloomer E, Goldblatt P. WHO European review of social determinants of health and the health divide. Lancet 2012; 380:1011-1029.
4. Cutler DM, Lleras-Muney A. Understanding differences in health behaviors by education. J Health Econ 2010; 29:1-28.
5. van Doorslaer E, Koolman X, Jones AM. Explaining incomerelated inequalities in doctor utilisation in Europe. Health Econ 2004; 13:629-647.
6. European Centre for Disease Prevention and Control. HIV testing: increasing uptake and effectiveness in the European Union. Stockholm: ECDC; 2010.
7. Hamers FF, Downs AM. The changing face of the HIV epidemic in western Europe: What are the implications for public health policies? Lancet 2004; 364:83-94.
8. European Centre for Disease Control/World Health Organisation. HIV/AIDS surveillanceinEurope. Stockholm:ECDC/WHO; 2010.
9. European Centre for Disease Prevention and Control. Thematic report:HIV treatment, care and support. Monitoring implantation of the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia:2012progress report. Stockholm: ECDC; 2013.
10. Royo-Bordonada MA, Diez-Cornell M, Llorente JM. Healthcare access for migrants in Europe: The case of Spain. Lancet 2013; 382:393-394.
11. Mocroft A, Lundgren JD, Sabin ML, Monforte A, Brockmeyer N, Casabona J, et al. Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE). PLoS Med 2013; 10:e1001510.
12. Marks G, Crepaz N, Senterfitt JW, Janssen RS. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr 2005; 39:446-453.
13. Moreno S, Mocroft A, Monforte A. Medical and societal consequences of late presentation. Antivir Ther 2010; 15 (Suppl 1): 9-15.
14. Adler NE, Newman K. Socioeconomic disparities in health: Pathways and policies. Health Aff (Millwood) 2002; 21:60-76.
15. Shavers VL. Measurement of socioeconomic status in health disparities research. J Natl Med Assoc 2007; 99:1013-1023.
16. Davey Smith G, Hart C, Hole D, MacKinnon P, Gillis C, Watt G, et al. Education and occupational social class: Which is the more important indicator of mortality risk? J Epidemiol Commun Health 1998; 52:153-160.
17. Regidor E, De Mateo S, Calle ME, Dominguez V. Educational level and mortality from infectious diseases. J Epidemiol Commun Health 2002; 56:682-683.
18. Wolbers M, Bucher HC, Furrer H, Rickenbach M, Cavassini M, Weber R, et al. Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study. HIV Med 2008; 9:397-405.
19. Sobrino-Vegas P, Rodriguez-Urrego J, Berenguer J, Caro-Murillo AM, Blanco JR, Viciana P, et al. Educational gradient in HIV diagnosisdelay, mortality, antiretroviral treatment initiation and response in a country with universal healthcare. Antivir Ther 2012; 17:1-8.
20. Girardi E, Aloisi MS, Arici C, Pezzotti P, Serraino D, Balzano R, et al. Delayed presentation and late testing for HIV: demographic and behavioral risk factors in a multicenter study in Italy. J Acquir Immune Defic Syndr 2004; 36:951-959.
21. Karanikolos M, Mladovsky P, Cylus J, Thomson S, Basu S, Stuckler D, et al. Financial crisis, austerity, and health in Europe. Lancet 2013; 381:1323-1331.
22. Antinori A, Coenen T, Costagiola D, Dedes N, Ellefson M, Gatell J, et al. Late presentation of HIV infection: A consensus definition. HIV Med 2011; 12:61-64.
23. Royston P, Ambler G, Sauerbrei W. The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol 1999; 28:964-974.
24. Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, et al. Multiple imputation for missing data in epidemiological and clinical research: Potential and pitfalls. Br Med J 2009; 338:b2393.
25. Royston P. Multiple imputation of missing values: further update of ice, with an emphasis on interval censoring. Stata J 2007; 7:445-464.
26. Ross C, Wu C. The links between education and health. Am Sociol Rev 1995; 60:719-745.
27. Cutler D, Lleras-Muney A. Education and health: evaluating theories and evidence. National Bureau of Economic Research. Bethesda, MD: BNER; 2006.
28. McGarrity LA, Huebner DM. Is being out about sexual orientation uniformly healthy? The moderating role of socioeconomic status in a prospective study of gay and bisexual men. Ann Behav Med 2013; 47:28-38.
29. Phillips A, Pezzotti P. Short-term risk of AIDS according to current CD4 cell count and viral load in antiretroviral drugnaive individuals and those treated in the monotherapy era. AIDS 2004; 18:51-58.
30. Deblonde J, Claeys P, Temmerman M. Antenatal HIV screening in Europe: A review of policies. Eur J Public Health 2007; 17:414-418.
31. Mustard CA, Etches J. Gender differences in socioeconomic inequality in mortality. J Epidemiol Commun Health 2003; 57:974-980.
32. White D, Stephenson R. Identity formation, outness, and sexual risk among gay and bisexual men. Am J Mens Health 2013; 8:98-109.
33. Lewden C, Raffi F, Cuzin L, Cailleton V, Vilde JL, Chene G, et al. Factors associated with mortality in human immunodeficiency virus type 1-infected adults initiating protease inhibitor-containing therapy: role of education level and of early transaminase level elevation (APROCO-ANRS EP11 study). The Antiproteases Cohorte Agence Nationale de Recherches sur le SIDA EP 11 study. J Infect Dis 2002; 186:710-714.
34. Bouhnik AD, Chesney M, Carrieri P, Gallais H, Moreau J, Moatti JP, et al. Nonadherence among HIV-infected injecting drug users: The impact of social instability. J Acquir Immune Defic Syndr 2002; 31 (Suppl 3):S149-153.
35. Protopopescu C, Carrieri MP, Le Moing V, Reboud P, Piroth L, Cuzin L, et al. Socio-behavioural determinants of mortality in HIV-infected patients receiving combined antiretroviral treatment (cART): results from the ANRS CO8 APROCO-COPILOTE cohort. 7th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Kuala Lumpur; 2013.
36. World Health Organization. Regional Office for Europe Health 2020: A European policy framework supporting action across government and society for health and well being. Malta, 10-13 September 2012.